Tags: Drug.

CX-614 is an ampakine drug developed by Cortex Pharmaceuticals. It has been investigated for its effect on AMPA receptors.Chronic CX-614 treatments produce rapid increases in the synthesis of the brain-derived neurotrophic factor BDNF which has very important effects on synaptic plasticity and may have applications in the treatment of neurodegenerative diseases such as Alzheimer’s disease.

CX614.png
CAS number
191744-13-5
FDA UNII code
87V631480W
IUPAC name
2H3H6aH-pyrrolidino(21-3'2')13-oxazino(6'5'-54)benzo(e)14-dioxan-10-one
PubChem
6451148

Loading...

This page contains content from the copyrighted Wikipedia article "CX614"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.